,i  #aadth ,,congress  #ast ,session    
,h4 ,r4 #bhgb  ,,in ,,the ,,house ,,of  
,,representatives  ,june #bd1 #bjae ,mr4
 ,bucshon 7for himself and ,mr4 ,womack7
 introduced the following bill2 which   
was referred to the ,committee on       
,energy and ,commerce1 and in addition  
to the ,committee on the ,judiciary1 for
 a period to be subsequently determined 
by the ,speaker1 in each case for       
consideration of such provisions as fall
 within the jurisdiction of the         
committee concerned  ,a ,,bill  ,to     
amend the ,controlled ,substances ,act  
to modernize the treatment of opioid    
addiction1 and for other purposes4  #a4 
,short title ,this ,act may be cited as 
the ,opioid ,addiction ,treatment       
,modernization ,act4  #b4 ,findings ,the
 ,congress finds that opioid addiction  
has become a public health epidemic that
 must be addressed by increasing        
awareness and access to all treatment   
options for opioid addiction1 overdose  
reversal1 and relapse prevention4  #c4  

,opioid addiction treatment             
modernization  7a7 ,in general ,section 
#cjc7;g7 of the ,controlled ,substances 
,act 7#ba ,u4,s4,c4 #hbc7;g77 is        
amended-- 7#a7 by adding at the end the 
following3  7#c7 ,the standards under   
paragraph 7#a77;,a7 7for determining    
whether a practitioner is qualified to  
engage in the treatment with respect to 
which registration is sought7 shall     
include a requirement for completion1   
every #b years1 of training-- 7,a7      
provided 7through classroom situations1 
seminars at professional society        
meetings1 electronic communications1 or 
otherwise7 by an organization such as   
the ,american ,society of ,addiction    
,medicine1 the ,american ,academy of    
,addiction ,psychiatry1 the ,american   
,medical ,association1 the ,american    
,osteopathic ,association1 the ,american
 ,psychiatric ,association1 the         
,american ,association for the          
,treatment of ,opioid ,dependence1 the  
,national ,council for ,behavioral      

,health1 or any other organization that 
the ,secretary determines is            
appropriate2 and  7,b7 addressing-- 7i7 
opioid detoxification2  7ii7 appropriate
 clinical use of all drugs approved by  
the ,food and ,drug ,administration for 
the treatment of opioid addiction2      
7iii7 the need for initial and periodic 
assessments of each patient2  7iv7 the  
development of an individualized        
treatment plan for each patient2 and    
7v7 the importance of providing overdose
 reversal and relapse prevention1 and   
appropriate counseling and other        
services4  2  7#b7 in paragraph         
7#b77;,b71 by inserting and annually    
thereafter1 after before the initial    
dispensing of narcotic drugs in schedule
 ,,iii1 ,,iv1 or ,v or combinations of  
such drugs to patients for maintenance  
or detoxification treatment12  7#c7 by  
amending paragraph 7#b77;,b77ii7 to read
 as follows3  7ii7 ,with respect to     
patients to whom the practitioner will  
provide such drugs or combinations of   

drugs1 the practitioner has the capacity
 to provide directly or by referral--   
7,i7 all drugs approved by the ,food and
 ,drug ,administration for the treatment
 of opioid addiction1 including1 as     
available1 opioid maintenance1          
detoxification1 and overdose reversal   
and relapse prevention2 and  7,,ii7     
appropriate counseling and ancillary    
services4  2  7#d7 by redesignating     
clause 7iii7 of paragraph 7#b77;,b7 as  
clause 7iv72  7#e7 after paragraph      
7#b77;,b77ii71 by inserting the         
following3  7iii7 ,the practitioner     
maintains a diversion control plan that 
contains specific measures to reduce the
 likelihood of the diversion of         
controlled substances prescribed by the 
practitioner for the treatment of opioid
 addiction4  2  7#f7 by amending        
paragraph 7#b77;,g77ii7 to read as      
follows3  7ii7 ,the term qualifying     
physician means a physician who meets   
the following3  7,i7 ,the physician is  
licensed under ,state law4  7,,ii7 ,the 

physician meets one or more of the      
following conditions3  7aa7 ,the        
physician holds a subspecialty board    
certification in addiction psychiatry   
from the ,american ,board of ,medical   
,specialties4  7bb7 ,the physician holds
 an addiction certification from the    
,american ,society of ,addiction        
,medicine4  7cc7 ,the physician holds a 
subspecialty board certification in     
addiction medicine from the ,american   
,osteopathic ,association4  7dd7 ,the   
physician has participated as an        
investigator in one or more clinical    
trials leading to the approval of a     
narcotic drug in schedule ,,iii1 ,,iv1  
or ,v for maintenance or detoxification 
treatment or the approval of a drug for 
the treatment of opioid addiction1 as   
demonstrated by a statement submitted to
 the ,secretary by the sponsor of such  
approved drug4  7ee7 ,the physician has 
such other training or experience as the
 ,state medical licensing board 7of the 
,state in which the physician will      

provide maintenance or detoxification   
treatment7 considers to demonstrate the 
ability of the physician to treat and   
manage opiate-dependent patients4  7ff7 
,the physician has such other training  
or experience as the ,secretary         
considers to demonstrate the ability of 
the physician to treat and manage       
opiate-dependent patients4 ,any criteria
 of the ,secretary under this item shall
 be established by regulation4 ,any such
 criteria are effective only for #c     
years after the date on which the       
criteria are promulgated1 but may be    
extended for such additional discrete   
#c-year periods as the ,secretary       
considers appropriate for purposes of   
this item4 ,such an extension of        
criteria may only be effectuated through
 a statement published in the ,federal  
,register by the ,secretary during the  
#cj-;day period preceding the end of the
 #c-year period involved4  7iii7 ,the   
physician completes1 with respect to the
 treatment and management of            

opiate-dependent patients1 not less than
 #h hours of training described in      
paragraph 7#c7 not less frequently than 
every #b years4  7iv7 ,the physician    
obtains in writing from each patient a  
signed acknowledgment that the patient--
  7,i7 will be subject to medication    
adherence and substance use monitoring2 
7,,ii7 understands available treatment  
options1 including drugs approved by the
 ,food and ,drug ,administration for the
 treatment of opioid addiction and their
 potential risks and benefits2 and      
7,,iii7 has an individualized treatment 
plan4  2 and  7#g7 by amending paragraph
 7#b77;,h77ii7 to read as follows3  7ii7
 ,not later than one year after the date
 of enactment of the ,opioid ,addiction 
,treatment ,modernization ,act1 the     
,secretary shall update the treatment   
improvement protocol containing best    
practice guidelines for the treatment of
 opiate-dependent patients4 ,the        
,secretary shall update such protocol in
 consultation with the ,director of the 

,national ,institute on ,drug ,abuse1   
the ,administrator of the ,drug         
,enforcement ,administration1 the       
,commissioner of ,food and ,drugs1 the  
,administrator of the ,substance ,abuse 
and ,mental ,health ,services           
,administration1 and other substance    
abuse disorder professionals4 ,updates  
to the protocol shall be guided by      
science4  4  7b7 ,inspection authority  
,the ,secretary of ,health and ,human   
,services or the ,attorney ,general of  
the ,united ,states may inspect persons 
that are registered under section       
#cjc7;g7 of the ,controlled ,substances 
,act 7#ba ,u4,s4,c4 #hbc7;g77 to ensure 
compliance with the requirements in this
 ,act 7and the amendments made by this  
,act7 with respect to which             
noncompliance may result in a revocation
 or suspension of the practitioner's    
registration4  7c7 ,certification of    
compliance ,not later than #a year after
 the date of enactment of this ,act1 all
 practitioners who1 as of such date of  

enactment1 are permitted to dispense    
narcotic drugs to individuals 7for      
maintenance treatment or detoxification 
treatment7 pursuant to paragraph 7#a7 or
 7#b7 of section #cjc7;g7 of the        
,controlled ,substances ,act 7#ba       
,u4,s4,c4 #hbc7;g77 shall submit a      
certification to the ,secretary of      
,health and ,human ,services of         
compliance with the provisions of such  
section #cjc7;g71 as amended by this    
,act4  7d7 ,reports to ,congress  7#a7  
,in general ,not later than #a year     
after the date of enactment of this     
,act1 and every #e years thereafter1 the
 ,comptroller ,general of the ,united   
,states shall--  7,a7 perform a thorough
 review of the provision of opioid      
addiction treatment services in the     
,united ,states2 and  7,b7 submit a     
report to the ,congress on the findings 
and conclusions of such review4  7#b7   
,contents ,each report under paragraph  
7#a7 shall include-- 7,a7 an assessment 
of compliance with the requirements of  

section #cjc7;g7 of the ,controlled     
,substances ,act1 as amended by this    
,act2  7,b7 a description of the        
measures taken by the ,secretary of     
,health and ,human ,services to ensure  
such compliance2 and  7,c7 an assessment
 of--  7i7 whether the full range of    
science- and evidence-based treatment   
options for opioid addiction are fully  
integrated into treatment2 and  7ii7 the
 circumstances surrounding medication   
diversion and misuse4